Published in Hepatitis Weekly, August 1st, 2005
According to recent research from Turkey, "although the most common major toxicity of lamivudine has been pancreatitis, there is no report investigating possible impaired pancreatic functions, including glucose intolerance due to lamivudine therapy. The aim of this study was to evaluate the effects of lamivudine on the glucose metabolism in children. Twenty-three children were included: eight patients were treated with lamivudine, others with both lamivudine and interferon-alpha."
"An oral glucose tolerance test (OGTT) was performed before the treatment, and after 6 and 12...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.